- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03157973
Modern Technology For Learning and Psychosocial Support In Patients With Abdominal Aortic Aneurysm
Study Overview
Detailed Description
Abdominal aortic anuerysm (AAA) is associated with a decreased health-related quality of life (HRQoL) both at diagnosis and during surgical treatment, although recent studies report somewhat contradictory results. In qualitative research, it has been shown that the health care system fails to meet the patients' information need, as well as their need for psychosocial support during the care process. The aim of this study is therefore to evaluate the effects of an intervention comprising an eHealth tool with individualized information in combination with structured follow-up with a contact nurse on anxiety, depression and HRQoL in patients undergoing surgical treatment for AAA.
Patients who are planned for elective surgical treatment, fulfil the inclusion criteria and none of the exclusion criteria will fill out questionnaires. The control group will receive information and follow-up per institution's standard of care. The intervention group will be given access to the eHealth tool, containing individualized information about the condition, surgical procedure and self-care. They will also receive structured follow-up by a contact nurse at discharge, 3 and 12 months postoperatively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 17176
- Department of Vascular Surgery, Karolinska University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ability to speak and understand Swedish
- Planned for elective surgical repair of an abdominal aortic aneurysm
Exclusion Criteria:
- Severe visual impairment or blindness
- Severe hearing impairment or deafness
- Diagnosed dementia
- Medical condition with a suspected life expectancy of < 1 year.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of Care
|
|
|
Experimental: Education intervention
|
eHealth tool and standardized nurse-led follow-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 12 months
|
A validated self-assessment scale that measures symptoms of anxiety and depression in a non-psychiatric population.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF12
Time Frame: 12 months
|
A 12-item questionnaire that measures 8 dimensions of physical and mental health.
|
12 months
|
|
Quality from the patient's perspective (QPP)
Time Frame: 12 months
|
A validated self-assessment scale measuring patient perceived quality of care.
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rebecka Hultgren, MD, PhD, Karolinska Institutet
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dnr 2016/1253-31/4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Aneurysm
-
W.L.Gore & AssociatesCMIC Co, Ltd. JapanRecruitingThoracoabdominal Aortic Aneurysm | Pararenal Aortic AneurysmJapan
-
University of BolognaCompletedThoracoabdominal Aortic Aneurysm | Ruptured Thoracic Aneurysm | Ruptured Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm, RupturedItaly
-
Baptist Health South FloridaBolton Medical; William Cook AustraliaRecruitingThoracoabdominal Aortic Aneurysm | Aortic Arch AneurysmUnited States
-
Karolinska University HospitalKarolinska Institutet; Swedish Heart Lung FoundationActive, not recruitingAortic Aneurysm | Aortic Aneurysm Abdominal | Abdominal AneurysmSweden
-
Aiatella OyRecruitingAortic Aneurysm | Aortic Aneurysm, Thoracoabdominal | Aortic Aneurysm Abdominal | Aortic Aneurysm and DissectionUnited States, Brazil
-
University of California, DavisUniversity of California, San DiegoRecruitingJuxtarenal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Pararenal Aortic Aneurysm | Complex Abdominal Aortic AneurysmUnited States
-
University of South FloridaMedtronic; Sanford HealthActive, not recruiting
-
University of North Carolina, Chapel HillCook Group Incorporated; UNC HospitalsEnrolling by invitationAortic Aneurysm, Abdominal | Aortic Arch Aneurysm | Ascending Aorta AneurysmUnited States
-
Mayo ClinicRecruiting
-
Rede Optimus Hospitalar SAShockwave Medical, Inc.RecruitingThoracoabdominal Aortic Aneurysm, Without Mention of Rupture | Abdominal Aortic Aneurysm Without Rupture | Thoracic Aortic Aneurysm Without RuptureItaly, Germany, Switzerland
Clinical Trials on Education intervention
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Roswell Park Cancer InstituteCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdvanced Malignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationCompleted
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Mayo ClinicTerminated
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedMalignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy